Genome-wide Association Study Identifies Novel Susceptibility Loci for Cutaneous Squamous Cell Carcinoma

Harvind S. Chahal,Yuan Lin,Katherine J. Ransohoff,David A. Hinds,Wenting Wu,Hong-Ji Dai,Abrar A. Qureshi,Wen-Qing Li,Peter Kraft,Jean Y. Tang,Jiali Han,Kavita Y. Sarin
DOI: https://doi.org/10.1038/ncomms12048
IF: 16.6
2016-01-01
Nature Communications
Abstract:Cutaneous squamous cell carcinoma represents the second most common cutaneous malignancy, affecting 7–11% of Caucasians in the United States. The genetic determinants of susceptibility to cutaneous squamous cell carcinoma remain largely unknown. Here we report the results of a two-stage genome-wide association study of cutaneous squamous cell carcinoma, totalling 7,404 cases and 292,076 controls. Eleven loci reached genome-wide significance ( P <5 × 10 −8 ) including seven previously confirmed pigmentation-related loci: MC1R , ASIP , TYR , SLC45A2 , OCA2 , IRF4 and BNC2 . We identify an additional four susceptibility loci: 11q23.3 CADM1 , a metastasis suppressor gene involved in modifying tumour interaction with cell-mediated immunity; 2p22.3; 7p21.1 AHR , the dioxin receptor involved in anti-apoptotic pathways and melanoma progression; and 9q34.3 SEC16A , a putative oncogene with roles in secretion and cellular proliferation. These susceptibility loci provide deeper insight into the pathogenesis of squamous cell carcinoma.
What problem does this paper attempt to address?